Figure 2From: A novel fusogenic herpes simplex virus for oncolytic virotherapy of squamous cell carcinomaCytopathic effect of R849 (a) or RH2 (b) in human oral SCC cells. SAS cells were infected with HSV-1 at an MOI of 0.01 and cultured at 37°C for 24 h. The infected cells were fixed and subjected to X-gal staining.Back to article page